Total Funding
55
21
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10478
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Craig Mello: Co-Founder & Scientific AdvisorPast Role: University of Massachusetts Medical School, Co-Director
Anastasia Khvorova: Co-Founder & Scientific Advisor
About the Company
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform.
Women Founded
Women Led
